Dbv Technologies operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Dbv Technologies with three other
pharmaceutical manufacturers in Europe:
sales of 75.81 million Norwegian Kroner [US$9.65 million]
Biotec Pharmacon ASA
(71.90 million Norwegian Kroner [US$9.15 million]
based in Sweden
(113.74 million Swedish Kronor [US$14.16 million]
Dbv Technologies reported sales of 9.08 million Euro (US$11.12 million)
December of 2016.
increase of 47.3%
versus 2015, when the company's sales were 6.17 million Euro.
Sales at Dbv Technologies have increased during each of the previous five years
(and since 2011, sales have increased a total of 7,107%).